Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 107 articles: HTML format Text format

Single Articles

March 2019
1. YOSHIDA T, Shida D, Taniguchi H, Tsukamoto S, et al
   Long-Term Outcomes Following Partial Versus Complete Cystectomy in Advanced Colorectal Cancer with Regarding to the Extent of Bladder Invasion.
   Ann Surg Oncol. 2019 Mar 7. pii: 10.1245/s10434-019-07276.
   PubMed     Text format     Abstract available
   
   
   
2. VELD JV, Amelung FJ, van Hooft JE, Tanis PJ, et al
   Letter to the Editor Regarding 'What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical
   Ann Surg Oncol. 2019 Mar 7. pii: 10.1245/s10434-019-07279.
   PubMed     Text format    
   
   
   
3. MEGE D, Sabbagh C, Manceau G, Karoui M, et al
   Response to Dr. Veld et al. Regarding the Manuscript Titled "What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score An
   Ann Surg Oncol. 2019 Mar 6. pii: 10.1245/s10434-019-07281.
   PubMed     Text format    
   
   
   
4. SOTIRCHOS VS, Fujisawa S, Vakiani E, Solomon SB, et al
   Fluorescent Tissue Assessment of Colorectal Cancer Liver Metastases Ablation Zone: A Potential Real-Time Biomarker of Complete Tumor Ablation.
   Ann Surg Oncol. 2019 Mar 4. pii: 10.1245/s10434-018-07133.
   PubMed     Text format     Abstract available
   
   
   February 2019
5. KELLY KJ, Alsayadnasser M, Vaida F, Veerapong J, et al
   Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?
   Ann Surg Oncol. 2019 Feb 27. pii: 10.1245/s10434-019-07255.
   PubMed     Text format     Abstract available
   
   
   
6. HA GW, Kim JH, Lee MR
   Oncologic Effects of Primary Tumor-Sidedness on Patients with Stages 1-3 Colon Cancer: A Meta-Analysis.
   Ann Surg Oncol. 2019 Feb 25. pii: 10.1245/s10434-019-07164.
   PubMed     Text format     Abstract available
   
   
   
7. SPINOGLIO G, Bianchi PP, Marano A, Priora F, et al
   Correction to: Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients.
   Ann Surg Oncol. 2019 Feb 25. pii: 10.1245/s10434-019-07267.
   PubMed     Text format     Abstract available
   
   
   
8. SHIDA D, Tanabe T, Boku N, Takashima A, et al
   Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study.
   Ann Surg Oncol. 2019 Feb 4. pii: 10.1245/s10434-019-07209.
   PubMed     Text format     Abstract available
   
   
   January 2019
9. NARAYAN RR, Goldman DA, Gonen M, Reichel J, et al
   Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.
   Ann Surg Oncol. 2019 Jan 31. pii: 10.1245/s10434-019-07201.
   PubMed     Text format     Abstract available
   
   
   
10. TANAKA T, Kojima K, Yokota K, Tanaka Y, et al
    Comprehensive Genetic Search to Clarify the Molecular Mechanism of Drug Resistance Identifies ASCL2-LEF1/TSPAN8 Axis in Colorectal Cancer.
    Ann Surg Oncol. 2019 Jan 31. pii: 10.1245/s10434-019-07172.
    PubMed     Text format     Abstract available
    
    
    
11. YOMODA T, Sudo T, Kawahara A, Shigaki T, et al
    Correction to: The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells.
    Ann Surg Oncol. 2019 Jan 29. pii: 10.1245/s10434-019-07208.
    PubMed     Text format     Abstract available
    
    
    
12. HAMILTON TD, MacNeill AJ, Lim H, Hunink MGM, et al
    Cost-Effectiveness Analysis of Cytoreductive Surgery and HIPEC Compared With Systemic Chemotherapy in Isolated Peritoneal Carcinomatosis From Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2019 Jan 28. pii: 10.1245/s10434-018-07111.
    PubMed     Text format     Abstract available
    
    
    
13. LEE SY, Kim DW, Kang SI, Ihn MH, et al
    Impact of Family History on Prognosis of Patients with Sporadic Colorectal Cancer.
    Ann Surg Oncol. 2019 Jan 25. pii: 10.1245/s10434-019-07179.
    PubMed     Text format     Abstract available
    
    
    
14. JACOBSON R, Sherman SK, Dahdaleh F, Turaga KK, et al
    Correction to: Peritoneal Metastases in Colorectal Cancer.
    Ann Surg Oncol. 2019 Jan 16. pii: 10.1245/s10434-019-07173.
    PubMed     Text format     Abstract available
    
    
    
15. SOLOMON D, DeNicola NL, Feferman Y, Bekhor E, et al
    More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2019 Jan 14. pii: 10.1245/s10434-018-07087.
    PubMed     Text format     Abstract available
    
    
    
16. MEGE D, Sabbagh C, Manceau G, Bridoux V, et al
    What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical Association Multicenter Cohort
    Ann Surg Oncol. 2019 Jan 8. pii: 10.1245/s10434-018-07139.
    PubMed     Text format     Abstract available
    
    
    December 2018
17. YOMODA T, Sudo T, Kawahara A, Shigaki T, et al
    The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells.
    Ann Surg Oncol. 2018 Dec 19. pii: 10.1245/s10434-018-07110.
    PubMed     Text format     Abstract available
    
    
    
18. FLAHERTY DC, Bilchik AJ
    ASO Author Reflections: Can the Association Between Obesity and Colorectal Cancer Be Explained by an Unfavorable Tumor Immune Microenvironment?
    Ann Surg Oncol. 2018 Dec 6. pii: 10.1245/s10434-018-7011.
    PubMed     Text format    
    
    
    
19. CHOUDRY MHA, Shuai Y, Jones HL, Pai RK, et al
    Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies.
    Ann Surg Oncol. 2018;25:3950-3959.
    PubMed     Text format     Abstract available
    
    
    
20. KIM WR, Han YD, Min BS
    C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy.
    Ann Surg Oncol. 2018;25:3898-3905.
    PubMed     Text format     Abstract available
    
    
    November 2018
21. OSHI M, Margonis GA, Sawada Y, Andreatos N, et al
    Higher Tumor Burden Neutralizes Negative Margin Status in Hepatectomy for Colorectal Cancer Liver Metastasis.
    Ann Surg Oncol. 2018 Nov 27. pii: 10.1245/s10434-018-6830.
    PubMed     Text format     Abstract available
    
    
    
22. PASSOT G, Vauthey JN, Chun YS
    ASO Author Reflections: RAS Mutations in Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2018 Nov 12. pii: 10.1245/s10434-018-7020.
    PubMed     Text format    
    
    
    
23. CLEARY RK, Morris AM, Chang GJ, Halverson AL, et al
    Controversies in Surgical Oncology: Does the Minimally Invasive Approach for Rectal Cancer Provide Equivalent Oncologic Outcomes Compared with the Open Approach?
    Ann Surg Oncol. 2018;25:3587-3595.
    PubMed     Text format     Abstract available
    
    
    
24. ROUANET P, Bertrand MM, Jarlier M, Mourregot A, et al
    Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives.
    Ann Surg Oncol. 2018;25:3572-3579.
    PubMed     Text format     Abstract available
    
    
    October 2018
25. SOUWER ETD, Hultink D, Bastiaannet E, Hamaker ME, et al
    The Prognostic Value of a Geriatric Risk Score for Older Patients with Colorectal Cancer.
    Ann Surg Oncol. 2018 Oct 25. pii: 10.1245/s10434-018-6867.
    PubMed     Text format     Abstract available
    
    
    
26. CREASY JM, D'Angelica MI
    ASO Author Reflections: Primary Tumor Location and Long-Term Survival After Hepatic Resection for Metastatic Colon Cancer.
    Ann Surg Oncol. 2018 Oct 17. pii: 10.1245/s10434-018-6918.
    PubMed     Text format    
    
    
    
27. YOKOI K, Harada H, Yokota K, Ishii S, et al
    Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.
    Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6865.
    PubMed     Text format     Abstract available
    
    
    
28. PINAR I, Fransgaard T, Thygesen LC, Gogenur I, et al
    Long-Term Outcomes of Robot-Assisted Surgery in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6862.
    PubMed     Text format     Abstract available
    
    
    
29. SHINTO E, Hida JI, Ike H, Kobayashi H, et al
    A New N Staging System for Colorectal Cancer in the Era of Extended Lymphadenectomy.
    Ann Surg Oncol. 2018 Oct 1. pii: 10.1245/s10434-018-6786.
    PubMed     Text format     Abstract available
    
    
    
30. ACUNA SA, Chesney TR, Amarasekera ST, Baxter NN, et al
    Defining Non-inferiority Margins for Quality of Surgical Resection for Rectal Cancer: A Delphi Consensus Study.
    Ann Surg Oncol. 2018;25:3171-3178.
    PubMed     Text format     Abstract available
    
    
    September 2018
31. WEERINK LBM, Gant CM, van Leeuwen BL, de Bock GH, et al
    Long-Term Survival in Octogenarians After Surgical Treatment for Colorectal Cancer: Prevention of Postoperative Complications is Key.
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6766.
    PubMed     Text format     Abstract available
    
    
    
32. SPINOGLIO G, Bianchi PP, Marano A, Priora F, et al
    Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients.
    Ann Surg Oncol. 2018 Sep 14. pii: 10.1245/s10434-018-6752.
    PubMed     Text format     Abstract available
    
    
    
33. ANGKA L, Martel AB, Kilgour M, Jeong A, et al
    Natural Killer Cell IFNgamma Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery.
    Ann Surg Oncol. 2018 Sep 5. pii: 10.1245/s10434-018-6691.
    PubMed     Text format     Abstract available
    
    
    
34. ASARE EA, Vreeland TJ, Feig BW
    Resection of a Perirectal Leiomyosarcoma via a Posterior Transcoccygeal Approach.
    Ann Surg Oncol. 2018;25:2641.
    PubMed     Text format     Abstract available
    
    
    August 2018
35. MIRKIN KA, Kulaylat AS, Hollenbeak CS, Messaris E, et al
    Prognostic Significance of Tumor Deposits in Stage III Colon Cancer.
    Ann Surg Oncol. 2018 Aug 6. pii: 10.1245/s10434-018-6661.
    PubMed     Text format     Abstract available
    
    
    July 2018
36. LEE DW, Han SW, Kang JK, Bae JM, et al
    Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Ann Surg Oncol. 2018 Jul 30. pii: 10.1245/s10434-018-6681.
    PubMed     Text format     Abstract available
    
    
    
37. MARTIN L, Hopkins J, Malietzis G, Jenkins JT, et al
    Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
    Ann Surg Oncol. 2018 Jul 13. pii: 10.1245/s10434-018-6652.
    PubMed     Text format     Abstract available
    
    
    June 2018
38. HAMABE A, Park S, Morita S, Tanida T, et al
    Analysis of the Vascular Interrelationships Among the First Jejunal Vein, the Superior Mesenteric Artery, and the Middle Colic Artery.
    Ann Surg Oncol. 2018;25:1661-1667.
    PubMed     Text format     Abstract available
    
    
    
39. FIORENTINI G, Ratti F, Cipriani F, Catena M, et al
    Tips and Tricks for a Laparoscopic Approach to Paracaval Liver Segments.
    Ann Surg Oncol. 2018;25:1695-1698.
    PubMed     Text format     Abstract available
    
    
    
40. GOFFREDO P, Garancini M, Robinson TJ, Frakes J, et al
    A National-Level Validation of the New American Joint Committee on Cancer 8th Edition Subclassification of Stage IIA and B Anal Squamous Cell Cancer.
    Ann Surg Oncol. 2018;25:1654-1660.
    PubMed     Text format     Abstract available
    
    
    
41. VIGANO L, Darwish SS, Rimassa L, Cimino M, et al
    Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?
    Ann Surg Oncol. 2018;25:1676-1685.
    PubMed     Text format     Abstract available
    
    
    May 2018
42. OKUNO M, Goumard C, Kopetz S, Vega EA, et al
    RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2018 May 21. pii: 10.1245/s10434-018-6517.
    PubMed     Text format     Abstract available
    
    
    
43. NARAYANAN S, Kawaguchi T, Yan L, Peng X, et al
    Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
    Ann Surg Oncol. 2018 May 16. pii: 10.1245/s10434-018-6506.
    PubMed     Text format     Abstract available
    
    
    
44. VAN DEN BROEK J, Geenen R, Heijnen L, Kobus C, et al
    Adrenal Incidentalomas During Diagnostic Work-up of Colorectal Cancer Patients: What is the Risk of Metastases?
    Ann Surg Oncol. 2018 May 14. pii: 10.1245/s10434-018-6501.
    PubMed     Text format     Abstract available
    
    
    
45. JACOBSON R, Sherman SK, Dadaleh F, Turaga KK, et al
    Peritoneal Metastases in Colorectal Cancer.
    Ann Surg Oncol. 2018 May 10. pii: 10.1245/s10434-018-6490.
    PubMed     Text format    
    
    
    
46. SPASOJEVIC M, Mariathasan AB, Goscinski M, Thorgersen EB, et al
    Vertical Rectus Abdominis Musculocutaneous Flap Repair Improves Perineal Wound Healing after Abdominoperineal Resection for Irradiated Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2018;25:1357-1365.
    PubMed     Text format     Abstract available
    
    
    
47. WASIF N, Etzioni D, Habermann EB, Mathur A, et al
    Racial and Socioeconomic Differences in the Use of High-Volume Commission on Cancer-Accredited Hospitals for Cancer Surgery in the United States.
    Ann Surg Oncol. 2018;25:1116-1125.
    PubMed     Text format     Abstract available
    
    
    April 2018
48. PARK JS, Ng KS, Saw RPM, Thompson JF, et al
    Metastatic Melanoma to the Colon, Rectum, and Anus: A 50-Year Experience.
    Ann Surg Oncol. 2018 Apr 24. pii: 10.1245/s10434-018-6451.
    PubMed     Text format     Abstract available
    
    
    
49. BABCOCK BD, Aljehani MA, Jabo B, Choi AH, et al
    High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
    Ann Surg Oncol. 2018 Apr 19. pii: 10.1245/s10434-018-6484.
    PubMed     Text format     Abstract available
    
    
    
50. WEISER MR
    AJCC 8th Edition: Colorectal Cancer.
    Ann Surg Oncol. 2018 Apr 3. pii: 10.1245/s10434-018-6462.
    PubMed     Text format    
    
    
    
51. ZHOU H, Ruan C, Wang Z, Hu Z, et al
    Laparoscopic-Assisted Modified Intersphincter Resection for Ultralow Rectal Cancer.
    Ann Surg Oncol. 2018;25:947-948.
    PubMed     Text format     Abstract available
    
    
    March 2018
52. SHIDA D, Yoshida T, Tanabe T, Tsukamoto S, et al
    Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis.
    Ann Surg Oncol. 2018 Mar 23. pii: 10.1245/s10434-018-6436.
    PubMed     Text format     Abstract available
    
    
    
53. SIMONEAU E, Vauthey JN
    Progression of Colorectal Cancer Liver Metastasis After Chemotherapy: A New Test of Time?
    Ann Surg Oncol. 2018 Mar 19. pii: 10.1245/s10434-018-6439.
    PubMed     Text format    
    
    
    
54. FLAHERTY DC, Jalas JR, Sim MS, Stojadinovic A, et al
    The Negative Impact of Body Mass Index on the Tumor Microenvironment in Colon Cancer: Results of a Prospective Trial.
    Ann Surg Oncol. 2018 Mar 12. pii: 10.1245/s10434-018-6405.
    PubMed     Text format     Abstract available
    
    
    
55. NAGATA H, Ishihara S, Oba K, Tanaka T, et al
    Development and Validation of a Prediction Model for Postoperative Peritoneal Metastasis After Curative Resection of Colon Cancer.
    Ann Surg Oncol. 2018 Mar 5. pii: 10.1245/s10434-018-6403.
    PubMed     Text format     Abstract available
    
    
    
56. ARSONIADIS EG, Fan Y, Jarosek S, Gaertner WB, et al
    Decreased Use of Sphincter-Preserving Procedures Among African Americans with Rectal Cancer.
    Ann Surg Oncol. 2018;25:720-728.
    PubMed     Text format     Abstract available
    
    
    
57. BLOK RD, Musters GD, Borstlap WAA, Buskens CJ, et al
    Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer.
    Ann Surg Oncol. 2018;25:729-736.
    PubMed     Text format     Abstract available
    
    
    
58. STEWART CL, Gleisner A, Halpern A, Ibrahim-Zada I, et al
    Implications of Hyperthermic Intraperitoneal Chemotherapy Perfusion-Related Hyperglycemia.
    Ann Surg Oncol. 2018;25:655-659.
    PubMed     Text format     Abstract available
    
    
    February 2018
59. HOPKINS JJ, Skubleny D, Bigam DL, Baracos VE, et al
    Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus.
    Ann Surg Oncol. 2018 Feb 27. pii: 10.1245/s10434-018-6395.
    PubMed     Text format     Abstract available
    
    
    
60. DHIR M, Zenati MS, Jones HL, Bartlett DL, et al
    Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM).
    Ann Surg Oncol. 2018;25:550-557.
    PubMed     Text format     Abstract available
    
    
    January 2018
61. ALI SM, Pawlik TM, Rodriguez-Bigas MA, Monson JRT, et al
    Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis.
    Ann Surg Oncol. 2018;25:32-37.
    PubMed     Text format     Abstract available
    
    
    
62. PAQUETTE IM, Madoff RD, Sigurdson ER, Chang GJ, et al
    Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer.
    Ann Surg Oncol. 2018;25:38-45.
    PubMed     Text format     Abstract available
    
    
    
63. HUPKENS BJP, Maas M, Martens MH, van der Sande ME, et al
    Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?
    Ann Surg Oncol. 2018;25:197-203.
    PubMed     Text format     Abstract available
    
    
    December 2017
64. TAKAHASHI G, Yamada T, Iwai T, Takeda K, et al
    Oncological Assessment of Stent Placement for Obstructive Colorectal Cancer from Circulating Cell-Free DNA and Circulating Tumor DNA Dynamics.
    Ann Surg Oncol. 2017 Dec 12. pii: 10.1245/s10434-017-6300.
    PubMed     Text format     Abstract available
    
    
    November 2017
65. CREASY JM, Sadot E, Koerkamp BG, Chou JF, et al
    The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6264.
    PubMed     Text format     Abstract available
    
    
    
66. DURAES LC, Stocchi L, Steele SR, Kalady MF, et al
    The Relationship Between Clavien-Dindo Morbidity Classification and Oncologic Outcomes After Colorectal Cancer Resection.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6142.
    PubMed     Text format     Abstract available
    
    
    October 2017
67. TIERNAN JP, Jayne DG
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis.
    Ann Surg Oncol. 2017 Oct 31. doi: 10.1245/s10434-017-6200.
    PubMed     Text format    
    
    
    
68. OH BY, Park YA, Huh JW, Yun SH, et al
    Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6135.
    PubMed     Text format     Abstract available
    
    
    
69. POVOSKI SP, Hatzaras IS, Mojzisik CM, Arnold MW, et al
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis: A Reply.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6201.
    PubMed     Text format    
    
    
    
70. WATANABE K, Salah S, Saito N
    Comment on: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6199.
    PubMed     Text format    
    
    
    
71. BINAY SAFER V, Safer U, Yorulmaz E, Sahin Z, et al
    Comment: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6166.
    PubMed     Text format    
    
    
    
72. KLAVER CEL, van Huijgevoort NCM, de Buck van Overstraeten A, Wolthuis AM, et al
    Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
    Ann Surg Oncol. 2017 Oct 26. doi: 10.1245/s10434-017-6037.
    PubMed     Text format     Abstract available
    
    
    
73. PASSOT G, Kim BJ, Glehen O, Mehran RJ, et al
    Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
    Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6141.
    PubMed     Text format     Abstract available
    
    
    
74. SHIDA D, Tsukamoto S, Ochiai H, Kanemitsu Y, et al
    Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2017 Oct 23. doi: 10.1245/s10434-017-6133.
    PubMed     Text format     Abstract available
    
    
    September 2017
75. CLARKE CN, Lee MS, Wei W, Manyam G, et al
    Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
    Ann Surg Oncol. 2017 Sep 21. doi: 10.1245/s10434-017-6054.
    PubMed     Text format     Abstract available
    
    
    
76. DEMEY K, Wolthuis A, de Buck van Overstraeten A, Fieuws S, et al
    External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Sep 11. doi: 10.1245/s10434-017-6042.
    PubMed     Text format     Abstract available
    
    
    August 2017
77. LORIMER PD, Motz BM, Kirks RC, Boselli DM, et al
    Pathologic Complete Response Rates After Neoadjuvant Treatment in Rectal Cancer: An Analysis of the National Cancer Database.
    Ann Surg Oncol. 2017;24:2095-2103.
    PubMed     Text format     Abstract available
    
    
    
78. WHEALON MD, Gahagan JV, Sujatha-Bhaskar S, O'Leary MP, et al
    Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
    Ann Surg Oncol. 2017;24:2122-2128.
    PubMed     Text format     Abstract available
    
    
    
79. SCHNEIDER MA, Eshmuminov D, Lehmann K
    Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC.
    Ann Surg Oncol. 2017;24:2224-2232.
    PubMed     Text format     Abstract available
    
    
    
80. SEEBERG LT, Brunborg C, Waage A, Hugenschmidt H, et al
    Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:2113-2121.
    PubMed     Text format     Abstract available
    
    
    June 2017
81. YAMASHITA S, Sakamoto Y, Yamamoto S, Takemura N, et al
    Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma, Biliary Tract Cancer, and Colorectal Liver Metastases: A Comparative Study Based on Single-Center Experience of 319 Cases.
    Ann Surg Oncol. 2017;24:1557-1568.
    PubMed     Text format     Abstract available
    
    
    
82. LIM TZ, Chan DKH, Tan KK
    Endoscopic Stenting Does Not Worsen Long Term Outcomes Amongst Patients Presenting with Obstruction from Colorectal Cancers.
    Ann Surg Oncol. 2017;24:1618-1625.
    PubMed     Text format     Abstract available
    
    
    May 2017
83. HAWKINS AT, Wells KO, Krishnamurty DM, Hunt SR, et al
    Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases.
    Ann Surg Oncol. 2017;24:1195-1201.
    PubMed     Text format     Abstract available
    
    
    
84. ACHARYA A, Markar SR, Matar M, Ni M, et al
    Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis.
    Ann Surg Oncol. 2017;24:1165-1173.
    PubMed     Text format     Abstract available
    
    
    
85. VYCHNEVSKAIA K, Dumont F, Agostini J, Julie C, et al
    Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer.
    Ann Surg Oncol. 2017;24:1304-1311.
    PubMed     Text format     Abstract available
    
    
    
86. YAMASHITA S, Loyer E, Kang HC, Aloia TA, et al
    Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery.
    Ann Surg Oncol. 2017;24:1376-1377.
    PubMed     Text format     Abstract available
    
    
    
87. DREYER SB, Powell AG, McSorley ST, Waterston A, et al
    The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer.
    Ann Surg Oncol. 2017;24:1295-1303.
    PubMed     Text format     Abstract available
    
    
    
88. KULAYLAT AS, Hollenbeak CS, Stewart DB Sr
    Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
    Ann Surg Oncol. 2017;24:1281-1288.
    PubMed     Text format     Abstract available
    
    
    April 2017
89. CHOULIARAS K, Levine EA, Fino N, Shen P, et al
    Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).
    Ann Surg Oncol. 2017;24:890-897.
    PubMed     Text format     Abstract available
    
    
    
90. DHIR M, Ramalingam L, Shuai Y, Pakrafter S, et al
    Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases.
    Ann Surg Oncol. 2017;24:875-883.
    PubMed     Text format     Abstract available
    
    
    
91. CHAN CH, Liesenfeld LF, Ferreiro-Neira I, Cusack JC Jr, et al
    Preclinical Evaluation of Cathepsin-Based Fluorescent Imaging System for Cytoreductive Surgery.
    Ann Surg Oncol. 2017;24:931-938.
    PubMed     Text format     Abstract available
    
    
    
92. MEHTA AM, Huitema AD, Burger JW, Brandt-Kerkhof AR, et al
    Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution.
    Ann Surg Oncol. 2017;24:990-997.
    PubMed     Text format     Abstract available
    
    
    
93. IHEMELANDU C
    Inflammation-Based Prognostic Scores: Utility in Prognostication and Patient Selection for Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Metastasis of Colonic Origin.
    Ann Surg Oncol. 2017;24:884-889.
    PubMed     Text format     Abstract available
    
    
    
94. IHEMELANDU C, Sugarbaker PH
    Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
    Ann Surg Oncol. 2017;24:898-905.
    PubMed     Text format     Abstract available
    
    
    
95. WRIGHT GP, Marsh JW, Varma MK, Doherty MG, et al
    Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
    Ann Surg Oncol. 2017;24:906-913.
    PubMed     Text format     Abstract available
    
    
    
96. VIGANO L, Lopci E, Costa G, Rodari M, et al
    Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
    Ann Surg Oncol. 2017;24:1029-1036.
    PubMed     Text format     Abstract available
    
    
    
97. MACHADO MA, Surjan R, Basseres T, Makdissi F, et al
    Total Laparoscopic Reversal ALPPS.
    Ann Surg Oncol. 2017;24:1048-1049.
    PubMed     Text format     Abstract available
    
    
    March 2017
98. WAITE K, Youssef H
    The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review.
    Ann Surg Oncol. 2017;24:705-720.
    PubMed     Text format     Abstract available
    
    
    
99. THORGERSEN EB, Goscinski MA, Spasojevic M, Solbakken AM, et al
    Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2017;24:721-728.
    PubMed     Text format     Abstract available
    
    
    February 2017
100. LEE DY, Teng A, Pedersen RC, Tavangari FR, et al
     Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
     Ann Surg Oncol. 2017;24:311-318.
     PubMed     Text format     Abstract available
     
     
     
101. CHOI SH, Choi GH, Han DH, Kwon SW, et al
     Laparoscopic Right Hepatectomy: Toward Protocolization and Simplification.
     Ann Surg Oncol. 2017;24:554-555.
     PubMed     Text format     Abstract available
     
     
     January 2017
102. SIOULAS VD, Jorge S, Chern JY, Schiavone MB, et al
     Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy.
     Ann Surg Oncol. 2017;24:251-256.
     PubMed     Text format     Abstract available
     
     
     
103. WIMMER K, Schwarz C, Szabo C, Bodingbauer M, et al
     Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases.
     Ann Surg Oncol. 2017;24:236-243.
     PubMed     Text format     Abstract available
     
     
     
104. BEPPU N, Kimura F, Aihara T, Doi H, et al
     Patterns of Local Recurrence and Oncologic Outcomes in T3 Low Rectal Cancer (</=5 cm from the Anal Verge) Treated With Short-Course Radiotherapy With Delayed Surgery : Outcomes in T3 Low Rectal Cancer Treated With Short-Course Radiotherapy With Del
     Ann Surg Oncol. 2017;24:219-226.
     PubMed     Text format     Abstract available
     
     
     
105. MARGONIS GA, Sasaki K, Andreatos N, Kim Y, et al
     KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.
     Ann Surg Oncol. 2017;24:264-271.
     PubMed     Text format     Abstract available
     
     
     
106. DHIR M, Jones HL, Shuai Y, Clifford AK, et al
     Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case-Control Study.
     Ann Surg Oncol. 2017;24:150-158.
     PubMed     Text format     Abstract available
     
     
     
107. ORCUTT ST, Massarweh NN, Li LT, Artinyan A, et al
     Patterns of Care for Colorectal Liver Metastasis Within an Integrated Health System: Secular Trends and Outcomes.
     Ann Surg Oncol. 2017;24:23-30.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: